Corticosteroid vs. Ozone Subacromial Injections for Rotator Cuff Tendinopathy .
Comparison of ultrasound-guided subacromial corticosteroid and ozone (O(2)-O(3)) injections in the treatment of chronic rotator cuff tendinopathy: a randomized clinical trial
Korean J Pain. 2023 Jan 1; 36(1): 128–136.Forty- four patients with rotator cuff tendinopathies were randomized to receive a single subacromial injection of corticosteroid (n=22) or three weekly subacromial injections of ozone (n=22). The primary outcome measure was the Western Ontario Rotator Cuff (WORC) score. Secondary outcome measures include the Shoulder Pain and Disability Index (SPADI) and pain on a Visual Analog Scale (VAS). Outcomes were assessed at 4 and 12 weeks follow-up. Both groups demonstrated significant improvements from baseline in all outcomes. However, the clinical benefits of both treatments may be similar, as no differences in all outcomes were observed between groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
